Elsevier

Journal of Proteomics

Volume 221, 15 June 2020, 103779
Journal of Proteomics

The impact of rattlesnake venom on mice cerebellum proteomics points to synaptic inhibition and tissue damage

https://doi.org/10.1016/j.jprot.2020.103779Get rights and content

Highlights

  • Mice injected with C. d. terrificus venom show several proteins abundancies changing in the cerebellum.

  • Several biochemical processes changed over time with the injection of venom, such as metabolic processes and tissue damage.

  • Each time point analyzed showed an increase or decrease of components such as oxidative stress, DNA repair, and synapses.

  • A network analysis showed disturbances of diverse proteins that might be directly related to Crotalus envenomation.

Abstract

Snake envenomation is responsible for more than 130,000 deaths worldwide. In Brazil, the Crotalus rattlesnake is responsible for the second largest number of accidental snake bites in the country. Although there are many descriptions of the clinical and biochemical effects of Crotalus envenoming, there are few works describing the molecular events in the central nervous system of an organism due to envenomation. In this study, we analyzed the proteomic effect of Crotalus durissus terrificus snake venom on mice cerebellums. To monitor the envenomation over time, changes in the protein abundance were evaluated at 1 h, 6 h, 12 h and 24 h after venom injection by mass spectrometry. The analysis of the variation of over 4600 identified proteins over time showed a reduction in components of inhibitory synapse signaling, oxidative stress, and maintenance of neuronal cells, which paralleled increasing tissue damage and apoptosis factors. These analyses revealed the potential protein targets of the C. d. terrificus venom on the murine cerebellum, showing new aspects of the snake envenomation effect. These data may contribute to new therapeutic approaches (i.e., approaches directed at protein targets affected by the envenomation) on the treatment of envenomation by the neurotoxic C. d. terrificus snake venom.

Significance

Snakebites are a neglected global health problem that affects mostly rural and tropical areas of developing countries. It is estimated that over 5.4 million people are bitten by snakes each year, from which 2.7 million people are bitten by venomous snakes, resulting in disabilities such as amputations and in some cases leading to death.

The C. d. terrificus snake is the most lethal snake in Brazil. Studying the molecular changes upon envenomation in a specific tissue may lead to a better understanding of the envenomation process by C. d. terrificus snakebites.

Introduction

According to the World Health Organization, snakebites are a neglected health problem that affects mostly tropical and subtropical countries. Every year, ~2.7 million venomous snakes accidents occur worldwide, resulting in 130,000 deaths, 490,000 amputations, and other severe health problems [1]. In Brazil, according to the Brazilian Ministry of Health, 22,000 accidents occur with venomous snakes every year [2]. These accidents are mainly caused by four genera of venomous snakes found in the Brazilian territory: Bothrops, responsible for 90.5% of the accidents; Micrurus, responsible for 0.4% of the accidents; Lachesis, responsible for 1.4% of the accidents; and Crotalus, known as rattlesnakes, responsible for 7.7% of the accidents. Although Crotalus accidents are the second largest cause of snakebite accidents in the country, their lethality is the highest, reaching 1.87% [3].

Crotalus durissus snake venom is mainly composed of a mixture of peptides and other minor chemical compounds. Among these compounds are presynaptic neurotoxins that act on nerve terminals, inhibiting acetylcholine and causing motor paralysis [4,5]. Within the first six hours of accidental venom inoculation, patients typically report several eye-related problems, such as palpebral, uni- or bilateral ptosis, ophthalmoplegia, blurred vision, and diplopia, which is a consequence of the paralysis of the extrinsic and intrinsic musculature of the eyeball after impairment of the third pair of cranial nerves [6]. In addition to its neurotoxic activity, myotoxic and abnormal coagulant activities of the venom have been observed. The myotoxic activity can be observed in the most serious cases, where various painful systemic lesions occur against the muscular fibers, leading to a release of enzymes and myoglobin to the blood, which are excreted by the urine and turn it a reddish-brown color. The abnormal coagulant activity comes from a fraction containing a thrombin-like enzyme, which causes disturbances in blood coagulation in approximately 40% of patients [7]. In addition, C. durissus venom has also been described to be neurotoxic [8], nephrotoxic [9], and cardiotoxic [10,11].

A composition analysis of C. durissus venom revealed four major components. Crotoxin is the most abundant toxin in the venom (65% of dry weight) and has neurotoxic activity and a secondary hemolytic activity [12]. Crotamine is related to myotoxic effects [13]. Gyroxin causes strong involuntary contractions of the muscles and a severe loss of balance, making mice spin on their own axis after subjecting the animals to toxin injection [14]; additionally, gyroxin has also been described to transpose the blood-brain barrier [15]. Convulxin has been described to present the same effects of gyroxin in tests performed in mice, in addition to an abrupt and transient fall of arterial blood pressure and late hypotension in dogs [16].

These descriptions show the severity of the venom action in crotalic accidents and the need to rapidly neutralize these toxins in an injured individual. Currently, the antivenom antiophidic sera, first described by Albert Calmette in 1859 [17], is still used to treat snakebites. These sera are developed by injecting small amounts of snake venom in horses and then purifying the antibodies against the venom. However, many countries that present high incidences of snakebite accidents, especially in Asia and Africa, have few companies that produce the antiophidic sera, making obtaining the sera an aggravating problem for the treatment of this type of medical emergency [1].

Several studies have described the clinical features of C. durissus snakebites and many others have studied the venom composition of these snakes at the genomic, transcriptomic, and proteomic levels. Previous studies also evaluated the biological and therapeutic effects of specific molecules isolated from Crotalus snake venom. However, even though C. d. terrificus is responsible for the second largest number of envenomation accidents and the highest lethality in Brazil, no previous studies evaluated the effect of its venom on the central nervous system.

To obtain a comprehensive proteomic characterization of the effects of the C. d. terrificus venom in mice cerebellums, which is responsible for equilibrium, coordination, balance, motor learning, motor memory, and motor consolidation, we used high-resolution mass spectrometry-based proteomics to analyze mice cerebellums injected with the venom at different time points over the period when patients seek the hospital after a snakebite [18]. The results indicated effects not previously described in the literature, such as the perturbation of proteins involved in the blood brain barrier, synaptic transmission, and tissue damage. These data add a greater understanding of the mechanism of action for venom in the context of the ophidian accidents, thus yielding new approaches to the study of ophidian accidents.

Section snippets

C. d. terrificus venom

Venom was extracted at the herpetology department of the Butantan Institute, and the supplied venom was lyophilized by the Venom and Antivenom Strategic Nuclei of Butantan Institute. The department pooled venom extracted from 256 snakes collected at various Brazilian locations (the states of São Paulo, Goiás, Minas Gerais, Mato Grosso do Sul, and Paraná). The venom pool was quantified according to the curve protocol described by Markwell [19] and analyzed by SDS-PAGE, and its median lethal dose

Results

To obtain a comprehensive proteomic molecular characterization of the effects of the C. d. terrificus venom in the mice cerebellums, we used high-resolution mass spectrometry-based proteomics to analyze mice cerebellums at different time points after injection with the C. d. terrificus venom. Thirty-two mice were injected with C. d. terrificus venom in the gastrocnemius muscle and 32 animals were injected with the saline control. Five mice from each group were sacrificed at 1 h, 6 h, 12 h and

Discussion

The proteomic analysis of the mouse cerebellum after the inoculation of 0.5 LD50 C. d. terrificus venom pointed to proteomic variations from 1 h to 24 h, in which several proteins were exclusively expressed in the control group or in the venom-injected mice (Fig. 1A). From the enrichment analysis, all of the biological functional terms of each protein group that pointed to the enhancement or diminishment of the terms at each time point were analyzed in non-ranked and quantitative mass

Conclusion

The proteomic modulation events in the mice cerebellum after the C. d. terrificus venom injection in mice gastrocnemius muscle highlight the complex temporal dynamic of the envenomation process in one of the brain regions. The neurotoxicity of this snake venom and its effects on different brain regions still need to be elucidated. However, the proteomic data presented in this work have provided insights into the mechanisms of the venom-induced tissue damage, elucidating novel events that can

Declaration of Competing Interest

The authors declare that there is no conflict of interest.

Acknowledgments

We thank Dr. Marisa Maria Teixeira da Rocha and Dr. Anita Tanaka from the Herpetology Department, Butantan Institute for the provision of the snake venom; Prof. Graziella Eliza Ronsein, Dr. Eduardo Shigueo Kitano and Dr. Daniel de Carvalho Pimenta for useful discussion; Alyson Matheus de Araújo Ferreira for the design of the graphical abstract. This work was supported by grants 2013/07467-1, 2016/04000-3, 2017/17943-6 and 2015/50040-4 (FAPESP/GSK) from the São Paulo Research Foundation

References (79)

  • M. Tata et al.

    Vascularisation of the central nervous system

    Mech. Dev.

    (2015)
  • S.P. Muller et al.

    Crotoxin from Crotalus durissus terrificus venom: in vitro cytotoxic activity of a heterodimeric phospholipase A2 on human cancer-derived cell lines

    Toxicon.

    (2018)
  • S.P. Bush et al.

    Severe rattlesnake envenomation with anaphylaxis and rhabdomyolysis

    Ann. Emerg. Med.

    (1995)
  • K. Yamagata et al.

    Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids

    Neuron.

    (1993)
  • F.P.B. Nunes et al.

    Long-lasting anti-inflammatory properties of Crotalus durissus terrificus snake venom in mice

    Toxicon.

    (2007)
  • F.C. Patrão-Neto et al.

    Dexamethasone antagonizes the in vivo myotoxic and inflammatory effects of Bothrops venoms

    Toxicon.

    (2013)
  • J. Finsterer

    Leigh and Leigh-like syndrome in children and adults

    Pediatr. Neurol.

    (2008)
  • S. Lebon et al.

    A novel mutation in the human complex I NDUFS7 subunit associated with Leigh syndrome

    Mol. Genet. Metab.

    (2007)
  • S. Park et al.

    Irbit mediates synergy between Ca2+ and cAMP signaling pathways during epithelial transport in mice

    Gastroenterology.

    (2013)
  • H. Yamazaki et al.

    Tyr-167/Trp-168 in type 1/3 inositol 1, 4, 5-trisphosphate receptor mediates functional coupling between ligand binding and channel opening

    J. Biol. Chem.

    (2010)
  • P.P.Q. Torrez et al.

    Acute cerebellar dysfunction with neuromuscular manifestations after scorpionism presumably caused by Tityus obscurus in Santarém, Pará/Brazil

    Toxicon.

    (2015)
  • J. Šribar et al.

    A high affinity acceptor for phospholipase A2 with neurotoxic activity is a calmodulin

    J. Biol. Chem.

    (2001)
  • I. Križaj et al.

    Neuronal receptors for phospholipases A2 and β-neurotoxicity

    Biochimie.

    (2000)
  • F.-C. Bange et al.

    An interferon-induced protein with release factor activity is a tryptophanyl-tRNA synthetase

    FEBS Lett.

    (1992)
  • A.L. Risinger et al.

    Microtubule dynamics as a target in oncology

    Cancer Treat. Rev.

    (2009)
  • World Health Organization (WHO)

    Snakebite Envenoming

    (2017)
  • Brazilian National Grievance Notification Information System SINAN

    Epidemiological Data of Snakes in Brazil

  • Brazilian Ministry of Health

    Accidents by Venomous Animals: what to Do and How to Avoid Snakebite Accidents (Portuguese)

  • F.V. Fonseca et al.

    Characterization of a new platelet aggregating factor from crotoxin Crotalus durissus cascavella venom

    Protein J.

    (2006)
  • M.M. Azevedo-Marques et al.

    Envenomation caused by poisonous animals: poisonous snakes

    Med. (RibeiraoPreto. Online)

    (2003)
  • M.M. Azevedo Marques et al.
  • O.V. Brazil

    Pharmacology of crystalline crotoxin. II. Neuromuscular blocking action

    Mem. Inst. Butantan

    (1966)
  • W.A. Hadler et al.

    Pharmacology of crystalline crotoxin. IV. nephrotoxicity

    Mem. Inst. Butantan.

    (1966)
  • A.L. Bieber et al.

    Structural, biological and biochemical studies of myotoxin a and homologous myotoxins

    J. Toxicol. Toxin Rev.

    (1997)
  • J.A.A. da Silva et al.

    Gyroxin increases blood-brain barrier permeability to Evans blue dye in mice

    Toxicon.

    (2011)
  • A. Calmette

    The treatment of animals poisoned with snake venom by the injection of antivenomous serum

    Br. Med. J.

    (1896)
  • M.T. Jorge et al.

    Epidemiology and clinical features of South American rattlesnakes (Crotalus durissus) envenomation

    Rev. Inst. Med. Trop. Sao Paulo

    (1992)
  • R.S. Villarroel et al.

    Padronização da titulação da atividade tóxica de venenos botrópicos em camundongos [Standardization of the toxic activity titration of botropic venoms in mice]

    Mem. Inst. Butantan

    (1979)
  • T. Masuda et al.

    Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis

    J. Proteome Res.

    (2008)
  • Cited by (8)

    • Proteomic analysis reveals rattlesnake venom modulation of proteins associated with cardiac tissue damage in mouse hearts

      2022, Journal of Proteomics
      Citation Excerpt :

      Proteins downregulated at the 6 h time point mostly belong to GO categories related to impaired liver function, abnormal voluntary movement, and altered brain morphology. Interestingly, we previously reported changes in several proteins, including proteins related to brain morphology, in the cerebellum of mice treated with C. d. terrificus venom [30]. At the 12 h time point (Fig. 2C), we observed an increase in a protein GO category related to the abnormal number of granulocytes, which may indicate an activation of local immune activity against the venom.

    • Botanical treatments for snakebite in rural Ghana: A narrative review

      2021, Journal of Ethnopharmacology
      Citation Excerpt :

      The existing pharmacological data indicate that medicinal plants target various physiopathological and biochemical processes involved in the clinical manifestation of snakebites which have both local and systemic effects. Some clinical manifestations of snakebites include pain, hemorrhage, edema, dermo necrosis, myonecrosis, and can neutralize the toxic effects of various snake venoms (Montoni et al., 2020). Published reports have mentioned numerous mechanisms of inactivation of toxic components of snake venoms and the reduction of the effect of snake venom intoxication.

    View all citing articles on Scopus
    View full text